Cargando…
Toxicity Evaluation of the Naphthalen-2-yl 3,5-Dinitrobenzoate: A Drug Candidate for Alzheimer Disease
The presented study was designed to probe the toxicity potential of newly identified compound naphthalen-2-yl 3,5-dinitrobenzoate (SF1). Acute, subacute toxicity and teratogenicity studies were performed as per Organization of economic cooperation and development (OECD) 425, 407, and 414 test guidel...
Autores principales: | Anwar, Fareeha, Saleem, Uzma, Rehman, Atta-Ur, Ahmad, Bashir, Froeyen, Matheus, Mirza, Muhammad Usman, Kee, Lee Yean, Abdullah, Iskandar, Ahmad, Sarfraz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141749/ https://www.ncbi.nlm.nih.gov/pubmed/34040515 http://dx.doi.org/10.3389/fphar.2021.607026 |
Ejemplares similares
-
Toxicological Screening of 4-Phenyl-3,4-dihydrobenzo[h]quinolin-2(1H)-one: A New Potential
Candidate for Alzheimer’s Treatment
por: Anwar, Fareeha, et al.
Publicado: (2021) -
Acute Oral, Subacute, and Developmental Toxicity Profiling of Naphthalene 2-Yl, 2-Chloro, 5-Nitrobenzoate: Assessment Based on Stress Response, Toxicity, and Adverse Outcome Pathways
por: Anwar, Fareeha, et al.
Publicado: (2022) -
Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease
por: Mirza, Muhammad Usman, et al.
Publicado: (2020) -
In Silico Study and Pharmacological Evaluation of
Eplerinone as an Anti-Alzheimer’s Drug in STZ-Induced Alzheimer’s
Disease Model
por: Hira, Sundas, et al.
Publicado: (2020) -
2-Methyl-3,5-dinitrobenzoic acid
por: Tahir, M. Nawaz, et al.
Publicado: (2009)